Here are relevant reports on : bone-graft-substitute-market
-
Dental Bone Graft Substitutes Market by Type (Xenograft, Allograft, Synthetic Bone Grafts, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, Region - Global Forecast to 2031
The global dental bone graft substitutes market, valued at USD 1.30 billion in 2025, stood at USD 1.40 billion in 2026 and is projected to advance at a resilient CAGR of 6.5% from 2026 to 2031, culminating in a forecasted valuation of USD 2.04 billion by the end of the period. This market has been expanding rapidly due to rising oral diseases, including tooth loss, edema, and periodontal disease, particularly among the aging population. As a result, there is a growing demand for implant surgeries, which require bone enhancement procedures before the actual implant can be placed.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Europe Dental Bone Graft Substitutes Market by Type (Xenograft, Allograft, Synthetic Bone Grafts, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, Country - Forecast to 2031
The Europe Dental Bone Graft Substitutes market, valued at USD 411.1 million in 2025, stood at USD 441.3 million in 2026 and is projected to advance at a resilient CAGR of 6.4% from 2026 to 2031, culminating in a forecasted valuation of USD 641.5 million by the end of the period. The main factors driving this rise are the increased use of advanced regenerative materials in implantology and periodontal procedures.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Biosurgery Market by Product (Bone Graft Substitutes, Sealants (Natural (Gelatin, Collagen)), Hemostatic Agents, Soft-tissue Attachments (Synthetic, Biological)), Application (Orthopedic, Urological), End User (Hospitals, ASCs) - Global Forecast to 2030
The global biosurgery market, valued at US$14.96 billion in 2024, stood at US$15.83 billion in 2025 and is projected to advance at a resilient CAGR of 6.4% from 2025 to 2030, culminating in a forecasted valuation of US$21.59 billion by the end of the period. Some of the prominent players operating in the market include market Medtronic (Ireland), Johnson & Johnson Services, Inc. (US), Baxter (US), Becton, Dickinson and Company (BD) (US), B. Braun SE (Germany), Stryker (US), Integra Lifesciences Holdings Corporation (US), CSL Ltd. (Australia), Hemostasis LLC (US), and Pfizer Inc. (US), among others.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Dental Biomaterials Market by Type (Metallic (Titanium, Stainless Steel, Chromium Alloy, Amalgam, Gold), PFM, Ceramic, Bone Graft, Polymer Biomaterials), Application (Implantology, Prosthetic, Orthodontic), End User & Region - Global Forecasts to 2023
The dental biomaterials market is projected to reach USD 9.6 billion by 2023, at a CAGR of 7.4%. The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth. The prominent players in the dental biomaterials market include Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland).
- Published: January 2019
- Price: $ 4950
- TOC Available:
-
Orthopedic Devices Market by Product (Fixation, Replacement, Prosthetics, Spinal Implant, Brace, Orthobiologics (DBM), Bone Graft), Procedures Volume (Knee, Hip, Ankle, Shoulder) Site, Application, End User (Hospital, ASC, Trauma) - Global Forecast to 2030
The global orthopedic devices market, valued at US$49.63 billion in 2023, stood at US$51.61 billion in 2024 and is projected to advance at a resilient CAGR of 4.8% from 2024 to 2030, culminating in a forecasted valuation of US$68.51 billion by the end of the period. The primary driver of the market is the increasing prevalence of orthopedic disorders, especially in the geriatric population. The growth is also propelled by efforts by the market leaders in terms of new product launches for orthopedic devices.
- Published: March 2025
- Price: $ 12000
- TOC Available:
-
Craniomaxillofacial Implants Market by Type (Mid Face, Plates, Screws, Mandibular Orthognathic Implants, Neuro, Mesh, Bone Graft, Dural Repair), by Material of Construction (Titanium, Polymer), by Application Site & Property - Global Forecast to 2021
The global Craniomaxillofacial implants market size is projected to grow at a CAGR of 6.9%. The market is broadly classified into type, application site, material of construction, property and regions.
- Published: May 2016
- Price: $ 4950
- TOC Available:
-
Spine Biologics Market by Product Type (Bone Graft, Bone Graft Substitute, Platelet Rich Plasma, BMAC), Surgery Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End User, and Geography - Global Forecast to 2020
Spinal biologics encompass materials that can be utilized in case of bone fusion surgery, spinal cord injury, and degenerative disk disease. Ten years ago, the spine treatment market constituted 75% traditional rods and plates made of metals and 25% biologics. However, since metals are inert materials, they did not stimulate the bone regeneration process. On the other hand, biological materials are proteins that can attract and stimulate cells, promote fusion, and help in the bone healing process. . The global spine biologics market is expected to reach $2.4 Billion by 2020, at a CAGR of 4.4% during the forecast period from 2015 to 2020.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Abdominal Aortic Aneurysm Repair Market by Product (Stent Graft, Synthetic Stent Graft, Catheter, Guidewire, Vascular Closure Devices, Balloon Inflation Devices), Site (Intrarenal, Para renal (Juxta renal, Suprarenal)) Global Forecast to 2023
The global abdominal aortic aneurysm repair (AAA) market is expected to reach USD 2.40 billion in 2023 from USD 1.64 billion in 2018, growing at a CAGR of 7.9%. Increasing prevalence of atherosclerosis, syphilis and medical cystic necrosis; and rising geriatric population are the major driving factors for this market. In addition to this, technological advancements in the medical devices, availability of reimbursement for medical devices and treatment are other supporting factors for this market. However, entry barriers to new players; and stringent government regulations.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Bone Cement & Glue Market by Bone Cement (PMMA, Calcium Phosphate), Bone Glue (Natural, Synthetic), Loading (Antibiotic Loaded), Application (Arthroplasty, Kyphoplasty, Vertebroplasty), End User (Hospitals, ASCS, Clinics) & Region - Global Forecast to 2028
The global bone cement & glue market, valued at US$1,549 million in 2022, stood at US$1,644 million in 2023 and is projected to advance at a resilient CAGR of 6.5% from 2023 to 2028, culminating in a forecasted valuation of US$2,248 million by the end of the period. The growth of this market is majorly driven by Growing number of road traffic accidents and rising number of surgical procedures However, extensive clinical data requirements for launching new bone cements may restrain the growth of this market.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Bone Growth Stimulator Market by Product (Device (External Bone Growth Stimulators), Platelet-Rich Plasma), Application (Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries), End User (Hospital, Ambulatory Surgical Centers) & Region - Global Forecast to 2027
The global bone growth stimulator market in terms of revenue was estimated to be worth $1.4 billion in 2022 and is poised to reach $1.8 billion by 2027, growing at a CAGR of 5.9% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: October 2022
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
